Investor · 1 deal
Every published round Bionics Institute took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| EpiMinder | Bridge / extension | 21 Mar 2022 | $16m | Participant | Startup Daily (2 Dec 2025), Startup Daily (21 Mar 2022), @AuManufacturing, Startup Daily (15 Mar 2022) |
Companies Bionics Institute has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| EpiMinder | Maker of a continuous seizure monitoring system for epilepsy | 21 Mar 2022, Bridge / extension | 1 | 0 |
Fund closes reported for Bionics Institute, as distinct from the investments it has made.
Companies Bionics Institute has backed that another company then bought. An exit for the holding, not a deal Bionics Institute did.
Stories naming Bionics Institute. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Medical device firm Epiminder has joined the ASX, its shares dipping below issue price on debut, with the $125 million IPO proceeds earmarked for an American launch of its implantable epilepsy monitoring system next year.
Also Startup Daily
Weekly roundup covering five Australian startups' raises: an insurtech Series E, a digital ID Series A, medtech and proptech funding, and a recycling platform's equity crowdfunding campaign.
Breakthrough Victoria details its $5 million convertible note investment in Neo-Bionica, a Melbourne medtech manufacturer co-founded by the University of Melbourne and Bionics Institute, which earlier received $4 million from the Victorian Government.
Also @AuManufacturing
Breakthrough Victoria is putting $5 million into Neo-Bionica, a Melbourne medical device manufacturer, to grow its prototyping, clinical trial and production capabilities, with the company expecting as many as 45 additional roles.
Also Breakthrough Victoria·SmartCompany·Startup Daily·@AuManufacturing·SmartCompany·Startup Daily·@AuManufacturing
Melbourne university funds backed a psychedelic medicines startup; six campus startups were showcased, and Tanarra Capital reported $100 million committed toward its alumni founders fund target.
Ignition Lane's weekly roundup covers Linktree's unicorn raise, several Australian funding rounds, Tiger and Insight's new mega-funds, falling SaaS valuations, the ACCC's action against Meta, and new accelerator and product launches.
Epiminder raised A$18 million in bridge funding for its epilepsy monitoring implant, backed by existing shareholders including Cochlear, after completing an A$18 million Series A in October 2021.
Epi-Minder has completed a $16 million bridge round with its existing shareholders to fund expanded clinical trials, product development and manufacturing of its long-term epilepsy monitoring device.